e-Therapeutics plc (LON:ETX)

e-Therapeutics plc (LON:ETX)

Share Price
3.10 p
0 (0.00 %)
Market Cap
£8.34 m
Proactive Investors - Run By Investors For Investors

e-Therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology. 

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

Market: AIM:ETX
52-week High/Low: 8.65p / 1.40p
Sector: Pharma & Biotech
Market Cap: £8.34 m
Website: www.etherapeutics.co.uk
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of e-Therapeutics plc

e-Therapeutics plc Timeline

Research Video

Riccardo Lowi on e-Therapeutics PLC

Riccardo Lowi, analyst at Capital Network talks through e-therapeutics' FY 2018 results showing good progress on the main research programs.
e-therapeutics reported results for the full year to Jan 31st 2018; business updates reflect good progress on the main research programs. Cash balance of £9.6mn was slightly higher than we expected, thanks to careful cost management.  
Dr Raymond Barlow brings with him a “broad experience of drug discovery, development and commercialisation, acquired through regional and global roles in the biotech and pharmaceutical sector”, ETX said.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use